U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06991452) titled 'Early Diagnosis and Recurrence Monitoring of Colorectal Cancer' on May 13.
Brief Summary: Colorectal cancer (CRC) has an insidious onset and its survival rate is closely related to clinical stage. While the 5-year survival rate of stage I patients exceeds 90%, it drops to 14% in stage IV. In China, only 15.2% of CRC cases are diagnosed at stage I, far below the rate in developed countries like the United States (24.1%). Early detection and screening are key to reducing CRC mortality and improving patient outcomes. However, current screening methods-including colonoscopy, fecal immunochemical tests (FIT), and emerging stool or blood-b...